Immunovant (IMVT) EPS (Diluted) (2020 - 2026)
Immunovant (IMVT) posted EPS (Diluted) of -$0.75 for fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with -$0.71 a year earlier.
Powered by 
Analysis
Immunovant (IMVT) EPS (Diluted) (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EPS (Diluted) at Immunovant was -$2.62; for FY2026 (ended Mar 31, 2026), it was -$2.77.
- In prior fiscal years, Immunovant's EPS (Diluted) was -$2.73 in FY2025, -$1.88 in FY2024, -$1.71 in FY2023 and -$1.43 in FY2022.
- Quarterly EPS (Diluted) has run from a low of -$0.81 in fiscal Q4 2026 to a high of -$0.35 in fiscal Q2 2022 over five years.
- According to Business Quant data, EPS (Diluted) for the three prior fiscal quarters was -$0.81 (Q4 2026), -$0.61 (Q3 2026) and -$0.73 (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 7.94 |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 2.27 |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 2.04 |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -0.54 |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 1.67 |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 1.60 |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 4.37 |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -8.44 |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | -0.04 |
| 10 | Immunovant | 5.85 Bn | 2.63 Bn | - | -0.75 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.75 |
| Mar 31, 2026 | -0.81 |
| Dec 31, 2025 | -0.61 |
| Sep 30, 2025 | -0.73 |
| Jun 30, 2025 | -0.71 |
| Mar 31, 2025 | -0.70 |
| Dec 31, 2024 | -0.76 |
| Sep 30, 2024 | -0.74 |
| Jun 30, 2024 | -0.60 |
| Mar 31, 2024 | -0.55 |
| Dec 31, 2023 | -0.36 |
| Sep 30, 2023 | -0.45 |
| Jun 30, 2023 | -0.57 |
| Mar 31, 2023 | -0.48 |
| Dec 31, 2022 | -0.49 |
| Sep 30, 2022 | -0.41 |
| Jun 30, 2022 | -0.35 |
| Mar 31, 2022 | -0.43 |
| Dec 31, 2021 | -0.36 |
| Sep 30, 2021 | -0.35 |
API Access
Immunovant EPS (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=eps-diluted&ticker=IMVT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "eps-diluted", "ticker": "IMVT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=eps-diluted&ticker=IMVT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();